BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
FGBI
First Guaranty Bancshares, Inc.
There isn't enough reported data to score FGBI yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FGBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
FGBI's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like FGBI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FGBI PE Valuation
FGBI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 23x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FGBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect FGBI to return to profit, with revenue growing.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FGBI on earnings quality, reporting a profit while its opponent remains loss making.
FGBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.57 | — |
| Q2 2026 | -$2.57 | -$1.56 |
| Q1 2026 | -$3.35 | -2677% |
| Q4 2025 | -$4.03 | -598% |
| Q3 2025 | -$4.13 | -592% |
| Q2 2025 | -$1.01 | -222% |
| Q1 2025 | $0.13 | -73% |
| Q4 2024 | $0.81 | +31% |
| Q3 2024 | $0.84 | -14% |
FGBI lost $2.57 per share over the past year, a bigger loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FGBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FGBI on profitability, with a higher operating margin.
FGBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $24.2M | -0.9% |
| Q1 2026 | $22.9M | -6.8% |
| Q4 2025 | $22.3M | -11% |
| Q3 2025 | $24.1M | -11% |
| Q2 2025 | $24.4M | -34% |
| Q1 2025 | $24.6M | +1.4% |
| Q4 2024 | $25.1M | +6.2% |
| Q3 2024 | $27.1M | +18% |
FGBI's revenue has slid since its 2024 peak: $24M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +57 points |
| Q1 2026 | 15% | +48 points |
| Q4 2025 | 13% | +8.4 points |
| Q3 2025 | -224% | -233 points |
| Q2 2025 | -39% | -64 points |
| Q1 2025 | -33% | -45 points |
| Q4 2024 | 4.7% | -2.2 points |
| Q3 2024 | 9.2% | -0.9 points |
FGBI's operating margin was 18% last quarter, up 57 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FGBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.4M | +$3.2M |
| Q1 2026 | $50.4M | +873% |
| Q4 2025 | -$25.3M | -235% |
| Q3 2025 | $28.7M | +476% |
| Q2 2025 | -$18.6M | -381% |
| Q1 2025 | $5.2M | +1208% |
| Q4 2024 | $18.7M | +198% |
| Q3 2024 | $5M | +$11.8M |
FGBI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FGBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FGBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +530K shares |
| 1 year | +26% | +3.4M shares |
| 3 years | +50% | +5.4M shares |
| 5 years | +52% | +5.6M shares |
| Available history | +53% | +5.7M shares |
FGBI has 16M diluted shares, up 26% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FGBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -63.2x | Net Cash |
| Q4 2024 | -17.7x | Net Cash |
| Q3 2024 | -16.8x | Net Cash |
| Q2 2024 | -13.8x | Net Cash |
| Q1 2024 | -21.8x | Net Cash |
| Q4 2023 | -0.7x | Net Cash |
| Q3 2023 | -8.7x | Net Cash |
| Q2 2023 | -4.4x | Net Cash |
FGBI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FGBI.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FGBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.6 | Overbought |
| Stochastic | 90.4 | Overbought |
FGBI's weekly RSI is 74 (overbought) and its Stochastic is 90 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FGBI PE vs Financial Services Sector
| Metric | FGBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
FGBI has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FGBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.51 | 36% above |
| 20 week MA | $9.27 | 39% above |
| 50 week MA | $8.75 | 48% above |
| 100 week MA | $8.66 | 49% above |
| 200 week MA | $10.4 | 24% above |
FGBI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FGBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.8 | $16.5 | -16% |
| 2021 | $16.5 | $20.7 | +25% |
| 2022 | $20.7 | $23.9 | +16% |
| 2023 | $23.9 | $11.1 | -53% |
| 2024 | $11.1 | $11.5 | +3.1% |
| 2025 | $11.5 | $5.03 | -56% |
| 2026 YTD | $5.03 | $12.9 | +157% |
FGBI has the edge over BAC on returns for 2026, with the stronger performance.